Market Overview
Global Surgical Hemostats and Clamps Market is expected to reach at a high CAGR during the forecast period 2026-2033.
Surgeons employ hemostats, also comprehended as ring and locking forceps, for grabbing, carrying, and plying strong traction on tissues and objects, especially in procedures. Hemostatic forceps look similar to ring scissors. Hemostatic forceps generally include a locking mechanism anointed with a ratchet, which the surgeon utilizes for clamping. The jaws of locking forceps slowly complete as the surgeon "ratchet up" the clamp incrementally.
Surgeons utilize sealing hemostatic forceps to maintain tissue securely. When they are utilized to control blood gush, they are anointed as hemostats. As anesthesia permitted calmer and additionally protracted procedures, various designs of reliable artery forceps developed, including a catch and release means situated below the finger bows. The ends of the forceps are serrated in one direction or another for enhanced grasp. As the period passed, more delicate artery forceps were constructed.
The growing number of surgical process, market developments including mergers, acquisitions, products introductions, growing awareness among other factors are expected to boost the global surgical hemostats and clamps market growth in the forecast period. Further, the growing cases of chronic conditions and blood clotting blood clottin disorders are also expected to contribute to the global market growth in the forecast period.
Market Scope
| Metrics | Details |
| CAGR | High |
| Size Available for Years | 2023-2033 |
| Forecast Period | 2026-2033 |
| Data Availability | Value (US$) |
| Segments Covered | Product Type, Material, Usage, End-User, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Fastest Growing Region | Asia-Pacific |
| Largest Region | North America |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report Request for Sample
Market Dynamics
Increasing Number Product Introductions
The increasing number of product introductions into the market is expected to boost the global surgical hemostats and clamps market growth during the forecast period. For instance, in November 2022, Medtrade Products Ltd obtained CE certification for its Uterine Hemostatic Tamponade, CELOX, which is a substantial and state-of-the-art invention that delivers quick and adequate management of postpartum bleeding, a general and extreme difficulty of childbirth. Ascend Performance Materials introduced a new product line of medical grade nylon 6,6 resins and engineered materials for the healthcare market under its HiDura brand.
AtriCure, Inc., a top designer in surgical therapies and treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, introduced the EnCompass Clamp, a part of the Isolator Synergy Ablation System in the United States. The EnCompass Clamp obtained FDA 510(k) authorization for the ablation of cardiac tissue in cardiac surgery and was developed to make simultaneous surgical ablations additionally effective.
Increasing Number of Surgeries Conducted
The increasing number of surgeries conducted is also contributing to the global market growth during the forecast period.
According to the Organization for Economic Co-operation and Development (OECD), around 94.87 thousand cardiovascular surgeries were conducted in Portugal, 49.33 thousand cardiovascular surgeries were conducted in Denmark, 32.84 thousand cardiovascular surgeries were conducted in Ireland, and 21.5 thousand cardiovascular surgeries were conducted in Norway in 2021.
Shortage of Surgeons
The global surgical clamps and hemostats market growth hindrances enclose a shortage of surgeons. A 2021 information published by the American Association of Medical Colleges anticipates shortages of 15,800-30,200 in all surgical fortes by 2034. The high cost of medical education makes up for this ongoing physician shortage.
The multinational workforce gap for surgeons, obstetricians, and anesthetists is more than two million, with an assessed 1.27 million additional required by 2030 to reach minimal surgical workforce densities. Again, according to the American Society of Clinical Oncology, Inc., the void is assessed to be most significant in low-income nations, where the present surgeon availability is 22,000 lower than the evaluated optimal number of 28,000 surgeons. The present number of anesthetists in low-income nations slips 11,000 below the model-estimated need of 13,000 anesthetists.
The Threat of Surgical Site Infections
Surgical tools, be they disposable or reusable, are crucial in any surgical operation. Reusable surgical tools need to be appropriately sterilized or disinfected before usage. Nevertheless, the protocols are not consistently obeyed consequently, resulting in sterilization and disinfection failures, leading to a potential growth in the cases of surgical site infections. Infections surface in roughly 0.5% to 3% of patients experiencing surgery and are among the highly general healthcare-acquired infections. U.S. Department of Health & Human Services, SSIs surface in 2% to 4% of all individuals undergoing inpatient surgical operations.
Despite the majority of infections being treatable with antibiotics, SSIs remain a substantial reason for morbidity and mortality post-surgery. They are the top reason for readmissions to the clinic following surgery, and roughly 3% of patients who contract an SSI are estimated to die as an outcome. Thus, the threat if surgical site ifections from infected surgical tools including hemostats and clamps is expected to hamper the global market growth in the forecast period.
Market Segmentation Analysis
The global surgical hemostats and clamps market is segmented based on product type, material, usage, end-user and region.
Injections of Botulinum Toxin (Botox) Product Type Expected to Dominate Market
Owing to the increasing cases of cardiovascular disorders the demand for disposable hemostats and clamps is expected to dominate the global market growth during the forecast period. Cardiovascular disorders are a set of ailments of the heart & blood vessels and include coronary heart disorder, cerebrovascular disorder, rheumatic heart condition, and other disorders.
According to the International Society on Thrombosis and Hemostasis, annually, there are roughly 10 million patients of venous thromboembolism globally. Also, according to the same source, in Europe, there are over 544,000 Deep Vein Thrombosis (DVT) related deaths each year. Further, according to a report from the British Heart Foundation in 2021, over 7.6 million individuals were with heart & circulatory conditions and it causes nearly 25% of death in the UK.
Market Geographical Share
Increasing Number of Surgeries conducted in North America
The increasing number of surgeries conducted in North America the region is estimated to dominate the global market during the forecast period. For instance, according to an investigation publicized in November 2021, laparoscopic cholecystectomy is the most typical abdominal surgery conducted in the United States, with more than 750,000 performed yearly. Surgical clips are most typically employed as an option for suturing for ligation in individuals undergoing some surgical processes, specifically cholecystectomies.
Further, according to the American Society of Plastic Surgeons in 2019, about 1.8 million patients of cosmetic minimally-invasive procedures were conducted in the U.S. Further, the growing cases of cardiovascular disorders in this region also contributed to the regional market growth during the forecast period. For example, according to the Disorders of the Blood 2022 declaration by PhRMA issued in May 2022, over 3.2 million Americans live with a bleeding condition yearly. Cardiovascular diseases (CVDs) are the top reason for death globally, taking an assessed 17.9 million lives annually.
Key Developments
- February 2026: Teleflex Incorporated announced its full-year financial and scaling infrastructure outlook, highlighting the expanded commercial manufacturing footprint of its advanced surgical lines. This scaling supports the high-volume demand in ambulatory surgery centres for its comprehensive biosurgery portfolio, notably its newly cleared and indications-expanded QuikClot Control+ Hemostatic Device line.
- May 2025: Baxter International Inc. officially launched its newly engineered Hemopatch Sealing Hemostat variant across the United States following strategic clinical validation. This technological advancement introduced a unique room-temperature storage capability and an extended 3-year shelf life, allowing surgical teams to store the collagen pads directly in open and minimally invasive operating suites without refrigeration.
- April 2025: Teleflex Incorporated secured U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded Indications for Use of its QuikClot Control+ Hemostatic Device portfolio. The regulatory advancement upgraded its utility from specific organ-space restrictions to the temporary control of all grades of internal and external bleeding, directly addressing severe bleeding complications during complex open cardiac and general surgical procedures.
Market Companies
The major global players in the market include B. Braun SE, Cook, Tercica Inc, MicroPort Scientific Corporation, ATRICURE, INC, Integra LifeSciences, Revance Therapeutics, Inc., Silex Medical, LLC, Teleflex Incorporated, and Microline Surgical among others.
Why Purchase the Report?
- To visualize the global surgical hemostats and clamps market segmentation based on product type, material type, usage, end-user and region as well as understand key commercial assets and players
- Identify commercial opportunities by analyzing trends and co-development
- Excel data sheet with numerous data points of surgical hemostats and clamps market-level with all segments
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study
- Product mapping available as excel consisting of key product of all the major players
The global surgical hemostats and clamps market report would provide approximately 61 tables, 58 figures and 186 Pages.
Target Audience
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
